Related Experiment Videos
The Cheng-Prusoff relationship: something lost in the translation
1Department of Biochemical Sciences, Wellcome Research Laboratories, Beckenham, Kent, UK.
Trends in Pharmacological Sciences
|March 1, 1993
Summary
Pharmacologists can determine antagonist affinity (Kb) using simple inhibition curves, not just complex Schild analysis. A practical method bypasses the need for known agonist affinity, simplifying antagonist characterization.
Area of Science:
- Pharmacology
- Receptor binding assays
- Drug discovery
Background:
- Pharmacologists frequently use 'inhibition curves' to assess antagonists due to practical considerations.
- A common misconception suggests that determining antagonist affinity (Kb) from inhibition curves necessitates the Cheng-Prusoff equation, which requires prior knowledge of agonist affinity.
- This reliance on agonist affinity can be a limitation in experimental design and data interpretation.
Purpose of the Study:
- To critically examine the methodology of 'inhibition curve' construction in pharmacology.
- To demonstrate a theoretically sound method for estimating antagonist Kb values from inhibition curves without needing to know the agonist affinity.
- To provide a practical alternative to the Cheng-Prusoff equation for antagonist characterization.
Main Methods:
- Analysis of 'inhibition curve' data.
- Comparison of different mathematical models for data fitting.
- Theoretical derivation of an alternative equation for Kb estimation.
Main Results:
- The study identifies a specific equation, distinct from the Cheng-Prusoff equation, that is suitable for analyzing inhibition curves.
- This alternative equation allows for the reliable estimation of antagonist Kb values.
- Crucially, this method does not require prior knowledge of the agonist's affinity for the receptor.
Conclusions:
- Inhibition curves can be practically and theoretically utilized to derive valid antagonist Kb values.
- A specific, related equation enables Kb estimation without requiring knowledge of agonist affinity.
- This finding offers a more accessible and versatile approach for pharmacologists evaluating antagonists.